Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 1
2007 1
2010 1
2011 4
2012 1
2013 2
2014 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Optimising the management of early prostate cancer.
Kirby R. Kirby R. Practitioner. 2014 Apr;258(1770):15-8, 2. Practitioner. 2014. PMID: 24881167 Review.
One in eight men in the UK will be diagnosed with prostate cancer during their lifetime. The risk of prostate cancer is strongly age-related and is also linked with a Western lifestyle. ...The more first-degree relatives affected the greater the risk o …
One in eight men in the UK will be diagnosed with prostate cancer during their lifetime. The risk of prostate cancer …
Significant association of caveolin-1 (CAV1) genotypes with prostate cancer susceptibility in Taiwan.
Wu HC, Chang CH, Tsou YA, Tsai CW, Lin CC, Bau DT. Wu HC, et al. Anticancer Res. 2011 Feb;31(2):745-9. Anticancer Res. 2011. PMID: 21378366
BACKGROUND: Multiple lines of evidence have implicated the Caveolin-1 (CAV1) gene in prostate cancer progression. CAV1 is located within the locus at 7q31-33 associated with prostate cancer aggressiveness, and was identified as being overexpressed in …
BACKGROUND: Multiple lines of evidence have implicated the Caveolin-1 (CAV1) gene in prostate cancer progression. CAV1 is loca …
Interest in genetic prostate cancer susceptibility testing among african American men.
Weinrich S, Royal C, Pettaway CA, Dunston G, Faison-Smith L, Priest JH, Roberson-Smith P, Frost J, Jenkins J, Brooks KA, Powell I. Weinrich S, et al. Cancer Nurs. 2002 Feb;25(1):28-34. doi: 10.1097/00002820-200202000-00007. Cancer Nurs. 2002. PMID: 11838717
Six regions for prostate cancer genes have been identified, and it is anticipated that prostate cancer susceptibility testing will be available in the future. ...Two questions measured interest in genetic prostate cancer suscept …
Six regions for prostate cancer genes have been identified, and it is anticipated that prostate cancer suscep …
Health motivation and emotional vigilance in genetic testing for prostate cancer risk.
Li Y, Doukas DJ. Li Y, et al. Clin Genet. 2004 Dec;66(6):512-6. doi: 10.1111/j.1399-0004.2004.00351.x. Clin Genet. 2004. PMID: 15521978
Actual uptake of genetic testing for cancer susceptibility is generally lower than 50%, despite a high initial interest above 80%. ...Using hypothetical genetic testing for prostate cancer susceptibility as an example, we used surveys of 400 men …
Actual uptake of genetic testing for cancer susceptibility is generally lower than 50%, despite a high initial interest above …
The hOGG1 mutant genotype is associated with prostate cancer susceptibility and aggressive clinicopathological characteristics in the Korean population.
Yun SJ, Ha YS, Chae Y, Kim JS, Kim IY, Kim WJ. Yun SJ, et al. Ann Oncol. 2012 Feb;23(2):401-5. doi: 10.1093/annonc/mdr115. Epub 2011 Apr 22. Ann Oncol. 2012. PMID: 21515665 Free article.
A case-control study was conducted to evaluate the correlation between the susceptibility and clinicopathological outcomes of prostate cancer (CaP) and hOGG1 genotype. ...CONCLUSIONS: These results suggest that hOGG1 is associated with the susceptibility …
A case-control study was conducted to evaluate the correlation between the susceptibility and clinicopathological outcomes of pros …
Genetic prostate cancer risk assessment: common variants in 9 genomic regions are associated with cumulative risk.
Helfand BT, Fought AJ, Loeb S, Meeks JJ, Kan D, Catalona WJ. Helfand BT, et al. J Urol. 2010 Aug;184(2):501-5. doi: 10.1016/j.juro.2010.04.032. Epub 2010 Jun 17. J Urol. 2010. PMID: 20620408 Free PMC article.
More recently 4 additional prostate cancer susceptibility variants were identified on chromosomes 2p15, 10q11, 11q13 and Xp11. ...A cumulative model including the 9 single nucleotide polymorphisms provided greater prostate cancer risk stratifica …
More recently 4 additional prostate cancer susceptibility variants were identified on chromosomes 2p15, 10q11, 11q13 an …
Cyclooxygenase 2 genotypes influence prostate cancer susceptibility in Japanese Men.
Sugie S, Tsukino H, Mukai S, Akioka T, Shibata N, Nagano M, Kamoto T. Sugie S, et al. Tumour Biol. 2014 Mar;35(3):2717-21. doi: 10.1007/s13277-013-1358-y. Epub 2013 Nov 8. Tumour Biol. 2014. PMID: 24203817
This study demonstrated a relationship between the COX2 G1195A variant and prostate cancer risk. This polymorphism may merit further investigation as a potential genomic marker for the early detection of prostate cancer. Our results support the hypothe …
This study demonstrated a relationship between the COX2 G1195A variant and prostate cancer risk. This polymorphism may merit f …
Commentary on "identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array." Eeles RA, Olama AA, Benlloch S, Saunders EJ, Leongamornlert DA, Tymrakiewicz M, Ghoussaini M, Luccarini C, Dennis J, Jugurnauth-Little S, Dadaev T, Neal DE, Hamdy FC, Donovan JL, Muir K, Giles GG, Severi G, Wiklund F, Gronberg H, Haiman CA, Schumacher F, Henderson BE, Le Marchand L, Lindstrom S, Kraft P, Hunter DJ, Gapstur S, Chanock SJ, Berndt SI, Albanes D, Andriole G, Schleutker J, Weischer M, Canzian F, Riboli E, Key TJ, Travis RC, Campa D, Ingles SA, John EM, Hayes RB, Pharoah PD, Pashayan N, Khaw KT, Stanford JL, Ostrander EA, Signorello LB, Thibodeau SN, Schaid D, Maier C, Vogel W, Kibel AS, Cybulski C, Lubinski J, Cannon-Albright L, Brenner H, Park JY, Kaneva R, Batra J, Spurdle AB, Clements JA, Teixeira MR, Dicks E, Lee A, Dunning AM, Baynes C, Conroy D, Maranian MJ, Ahmed S, Govindasami K, Guy M, Wilkinson RA, Sawyer EJ, Morgan A, Dearnaley DP, Horwich A, Huddart RA, Khoo VS, Parker CC, Van As NJ, Woodhouse CJ, Thompson A, Dudderidge T, Ogden C, Cooper CS, Lophatananon A, Cox A, Southey MC, Hopper JL, English DR, Aly M, Adolfsson J, Xu J, Zheng SL, Yeager M, Kaaks R, Diver WR, Gaudet MM, Stern MC, Corral R, Joshi AD, Shahabi A, Wahlfors T, Tammela TL, Auvinen A, Virtamo J, Klarskov P, Nordestgaard BG, Roder MA, Nielsen SF, Bojesen SE, Siddiq A, Fitzgerald LM, Kolb S, Kwon EM, Karyadi DM, Blot WJ, Zheng W, Cai Q, McDonnell SK, Rinckleb AE, Drake B, Colditz G, Wokolorczyk D, Stephenson RA, Teerlink C, Muller H, Rothenbacher D, Sellers TA, Lin HY, Slavov C, Mitev V, Lose F, Srinivasan S, Maia S, Paulo P, Lange E, Cooney KA, Antoniou AC, Vincent D, Bacot F, Tessier DC; COGS-Cancer Research UK GWAS-ELLIPSE (part of GAME-ON) Initiative; Australian Prostate Cancer Bioresource; UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology; UK ProtecT (Prostate testing for cancer and Treatment) Study.
Olumi AF. Olumi AF. Urol Oncol. 2014 Feb;32(2):211. doi: 10.1016/j.urolonc.2013.08.019. Urol Oncol. 2014. PMID: 24445293
To identify common prostate cancer susceptibility alleles, we genotyped 211,155 SNPs on a custom Illumina array (iCOGS) in blood DNA from 25,074 prostate cancer cases and 24,272 controls from the international PRACTICAL Consortium. Twenty-three …
To identify common prostate cancer susceptibility alleles, we genotyped 211,155 SNPs on a custom Illumina array (iCOGS) …
Significant association of Glutathione S-transferase T1 null genotype with prostate cancer risk: a meta-analysis of 26,393 subjects.
Yang Q, Du J, Yao X. Yang Q, et al. PLoS One. 2013;8(1):e53700. doi: 10.1371/journal.pone.0053700. Epub 2013 Jan 24. PLoS One. 2013. PMID: 23365641 Free PMC article.
Overall, there was a significant association between GSTT1 null genotype and increased risk of prostate cancer (OR = 1.14, 95%CI 1.01-1.29, P = 0.034). Meta-analysis of adjusted ORs also showed a significant association between GSTT1 null genotype and increased risk …
Overall, there was a significant association between GSTT1 null genotype and increased risk of prostate cancer (OR = 1.14, 95% …
Application of a novel score test for genetic association incorporating gene-gene interaction suggests functionality for prostate cancer susceptibility regions.
Ciampa J, Yeager M, Jacobs K, Thun MJ, Gapstur S, Albanes D, Virtamo J, Weinstein SJ, Giovannucci E, Willett WC, Cancel-Tassin G, Cussenot O, Valeri A, Hunter D, Hoover R, Thomas G, Chanock S, Holmes C, Chatterjee N. Ciampa J, et al. Hum Hered. 2011;72(3):182-93. doi: 10.1159/000331222. Epub 2011 Nov 11. Hum Hered. 2011. PMID: 22086326 Free PMC article.
We use our method in applications designed to detect interactions that generate hypotheses about the functionality of prostate cancer (PRCA) susceptibility regions. METHODS: Our proposed score test is designed to gain additional power through the use of a ret …
We use our method in applications designed to detect interactions that generate hypotheses about the functionality of prostate can …
12 results